cancer Archives | Be Korea-savvy
Lower Income Cancer Patients Less Likely to Survive: Study

Lower Income Cancer Patients Less Likely to Survive: Study

SEOUL, Dec. 11 (Korea Bizwire) — A recent survey showed that the severity of cancer at the time of initial diagnosis differs by the patient’s income. All.Can Korea, a civic group devoted to tackling inefficient environments for treating cancer, conducted a survey of 495 cancer patients, 38.1 percent of whom had their first tumor discovered [...]

Helsinn Group Supports Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer Fund

Helsinn Group Supports Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer Fund

Lugano, Switzerland, June 10 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, today announces that Helsinn is supporting Conquer Cancer, the ASCO Foundation’s COVID Impacts Cancer fund, with a donation of US$100,000. The COVID Impacts Cancer campaign is an emergency initiative powered by Conquer Cancer and was created to support cancer [...]

Dog Anthelmintics Offer Solace to Terminally Ill Cancer Patients

Dog Anthelmintics Offer Solace to Terminally Ill Cancer Patients

SEOUL, Jan. 9 (Korea Bizwire) — Dog anthelmintics are becoming highly valued in South Korea as a panacea. Last October, comedian Kim Chul-min, a late-stage lung cancer patient, revealed that he had taken Fenbendazole for seven weeks. After weeks of taking the medication, his blood work all came back normal. Since then, there has been [...]

S. Korea Ranks Among Top OECD Member Countries in Treatment of Cancer

S. Korea Ranks Among Top OECD Member Countries in Treatment of Cancer

SEOUL, Nov. 17 (Korea Bizwire) — South Korea ranks as one of the leading members among the Organization for Economic Cooperation and Development (OECD) in the treatment of cancer, medical data showed Sunday. The 2019 Health at a Glance report released by the Paris-based organization said Asia’s fourth-largest economy had the highest five-year survival rate [...]

Black Belt TX Forms a Strategic Partnership with Praxis Biotech to Develop New Therapies Targeting Stress Response Pathways in Cancer

Black Belt TX Forms a Strategic Partnership with Praxis Biotech to Develop New Therapies Targeting Stress Response Pathways in Cancer

Stevenage, UK and San Francisco, U.S., Nov. 5 (Korea Bizwire) – Black Belt TX, a company focused on targeting stress response pathways in cancer, and Praxis Biotech, a biotech company focused on the discovery of small molecules modulating cellular stress mechanisms in different disease areas, have entered into a strategic partnership to jointly discover and [...]